Lv11
30 积分 2023-04-11 加入
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer
6小时前
待确认
Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia
1个月前
已完结
A BCMA-Targeted Bispecific Antibody Is Active in Multiple Myeloma
1个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
1个月前
已完结
48MO Phase I study of AMG 757, a delta-like ligand 3 (DLL3) targeting, half-life extended bispecific T-cell engager immuno-oncology therapy, in small cell lung cancer (SCLC)
1个月前
已完结
P1.12-18 Nonclinical Safety Assessment of AMG 757, a DLL3 Bispecific T Cell Engager, in the Cynomolgus Monkey
1个月前
已完结
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique
2个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
2个月前
已完结
Structural basis of assembly of the human T cell receptor–CD3 complex
2个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
